William Blair analyst Matt Phipps initiated coverage of Tenax Therapeutics with an Outperform rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on TENX: Tenax Therapeutics reports Q2 EPS ($1.83), consensus ($1.98) Tenax announces plans to accelerate oral levosimendan Phase 3 program Biotech Alert: Searches spiking for these stocks today 3 Penny Stocks to Watch Now, 8/8/24 Tenax Therapeutics announces oversubscribed $100M private placement Disclaimer & DisclosureReport an Issue